• Je něco špatně v tomto záznamu ?

ClinVar database of global familial hypercholesterolemia-associated DNA variants

MA. Iacocca, JR. Chora, A. Carrié, T. Freiberger, SE. Leigh, JC. Defesche, CL. Kurtz, MT. DiStefano, RD. Santos, SE. Humphries, P. Mata, CE. Jannes, AJ. Hooper, KA. Wilemon, P. Benlian, R. O'Connor, J. Garcia, H. Wand, L. Tichy, EJ. Sijbrands,...

. 2018 ; 39 (11) : 1631-1640. [pub] -

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19034968

Grantová podpora
PG08/008 British Heart Foundation - United Kingdom
U41 HG006834 NHGRI NIH HHS - United States
U41 HG009649 NHGRI NIH HHS - United States
U01 HG007436 NHGRI NIH HHS - United States
U41 HG009650 NHGRI NIH HHS - United States
U01 HG007437 NHGRI NIH HHS - United States
P30 DK116074 NIDDK NIH HHS - United States
NV16-29084A MZ0 CEP - Centrální evidence projektů

Accurate and consistent variant classification is imperative for incorporation of rapidly developing sequencing technologies into genomic medicine for improved patient care. An essential requirement for achieving standardized and reliable variant interpretation is data sharing, facilitated by a centralized open-source database. Familial hypercholesterolemia (FH) is an exemplar of the utility of such a resource: it has a high incidence, a favorable prognosis with early intervention and treatment, and cascade screening can be offered to families if a causative variant is identified. ClinVar, an NCBI-funded resource, has become the primary repository for clinically relevant variants in Mendelian disease, including FH. Here, we present the concerted efforts made by the Clinical Genome Resource, through the FH Variant Curation Expert Panel and global FH community, to increase submission of FH-associated variants into ClinVar. Variant-level data was categorized by submitter, variant characteristics, classification method, and available supporting data. To further reform interpretation of FH-associated variants, areas for improvement in variant submissions were identified; these include a need for more detailed submissions and submission of supporting variant-level data, both retrospectively and prospectively. Collaborating to provide thorough, reliable evidence-based variant interpretation will ultimately improve the care of FH patients.

Academic Medical Center University of Amsterdam Amsterdam Netherlands

Center for Inherited Cardiovascular Disease Stanford University Palo Alto California

Center of Molecular Biology and Gene Therapy University Hospital Brno Brno Czech Republic

Centre for Cardiovascular Genetics University College of London London United Kingdom

Centre for Cardiovascular Surgery and Transplantation Brno Czech Republic Ceitec and Medical Faculty Masaryk University Brno London

CNRS CHU Lille UMR 8199 Integrative Genomics and Metabolic Diseases Modeling University of Lille Lille France

Color Genomics Burlingame California

Department of Genetics University of North Carolina Chapel Hill North Carolina

FH Foundation Pasadena California

FH Foundation Pasadena California Center for Inherited Cardiovascular Disease Stanford University Palo Alto California

Fundacion Hipercolesterolemia Familiar Madrid Spain

Genomics England London United Kingdom

Harvard Medical School Harvard University Boston Massachusetts

Hôpitaux Universitaires Pitié Salpêtrière Charles Foix Molecular and Chromosomal Genetics Center Obesity and Dyslipidemia Genetics Unit Assistance Publique Hôpitaux de Paris Paris France Inserm Institute of Cardiometabolism and Nutrition Hôpital de la Pitié Sorbonne Université Paris France

Instituto do Coração São Paulo Brazil

Instituto Nacional de Saúde Doutor Ricardo Jorge Lisbon Portugal BioISI University of Lisbon Lisbon Portugal

Invitae Corporation San Francisco California

PathWest Laboratory Medicine University of Western Australia Perth Australia

Robarts Research Institute Western University London Ontario Canada

University Medical Center Erasmus University Rotterdam Netherlands

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19034968
003      
CZ-PrNML
005      
20191014101929.0
007      
ta
008      
191007s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/humu.23634 $2 doi
035    __
$a (PubMed)30311388
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Iacocca, Michael A $u Robarts Research Institute, Western University, London, Ontario, Canada.
245    10
$a ClinVar database of global familial hypercholesterolemia-associated DNA variants / $c MA. Iacocca, JR. Chora, A. Carrié, T. Freiberger, SE. Leigh, JC. Defesche, CL. Kurtz, MT. DiStefano, RD. Santos, SE. Humphries, P. Mata, CE. Jannes, AJ. Hooper, KA. Wilemon, P. Benlian, R. O'Connor, J. Garcia, H. Wand, L. Tichy, EJ. Sijbrands, RA. Hegele, M. Bourbon, JW. Knowles, ClinGen FH Variant Curation Expert Panel,
520    9_
$a Accurate and consistent variant classification is imperative for incorporation of rapidly developing sequencing technologies into genomic medicine for improved patient care. An essential requirement for achieving standardized and reliable variant interpretation is data sharing, facilitated by a centralized open-source database. Familial hypercholesterolemia (FH) is an exemplar of the utility of such a resource: it has a high incidence, a favorable prognosis with early intervention and treatment, and cascade screening can be offered to families if a causative variant is identified. ClinVar, an NCBI-funded resource, has become the primary repository for clinically relevant variants in Mendelian disease, including FH. Here, we present the concerted efforts made by the Clinical Genome Resource, through the FH Variant Curation Expert Panel and global FH community, to increase submission of FH-associated variants into ClinVar. Variant-level data was categorized by submitter, variant characteristics, classification method, and available supporting data. To further reform interpretation of FH-associated variants, areas for improvement in variant submissions were identified; these include a need for more detailed submissions and submission of supporting variant-level data, both retrospectively and prospectively. Collaborating to provide thorough, reliable evidence-based variant interpretation will ultimately improve the care of FH patients.
650    _2
$a DNA $x genetika $7 D004247
650    _2
$a databáze genetické $7 D030541
650    _2
$a genetická variace $x genetika $7 D014644
650    _2
$a genom lidský $x genetika $7 D015894
650    _2
$a genomika $7 D023281
650    _2
$a lidé $7 D006801
650    _2
$a hyperlipoproteinemie typ II $x genetika $7 D006938
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Chora, Joana R $u Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal. BioISI, University of Lisbon, Lisbon, Portugal.
700    1_
$a Carrié, Alain $u Hôpitaux Universitaires Pitié-Salpêtrière/Charles-Foix, Molecular and Chromosomal Genetics Center, Obesity and Dyslipidemia Genetics Unit, Assistance Publique-Hôpitaux de Paris, Paris, France. Inserm, Institute of Cardiometabolism and Nutrition, Hôpital de la Pitié, Sorbonne Université, Paris, France.
700    1_
$a Freiberger, Tomáš $u Centre for Cardiovascular Surgery and Transplantation, Brno, Czech Republic. Ceitec and Medical Faculty, Masaryk University, Brno, London.
700    1_
$a Leigh, Sarah E $u Genomics England, London, United Kingdom.
700    1_
$a Defesche, Joep C $u Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
700    1_
$a Kurtz, C Lisa $u Department of Genetics, University of North Carolina, Chapel Hill, North Carolina.
700    1_
$a DiStefano, Marina T $u Harvard Medical School, Harvard University, Boston, Massachusetts.
700    1_
$a Santos, Raul D $u Instituto do Coração, São Paulo, Brazil.
700    1_
$a Humphries, Steve E $u Centre for Cardiovascular Genetics, University College of London, London, United Kingdom.
700    1_
$a Mata, Pedro $u Fundacion Hipercolesterolemia Familiar, Madrid, Spain.
700    1_
$a Jannes, Cinthia E $u Instituto do Coração, São Paulo, Brazil.
700    1_
$a Hooper, Amanda J $u PathWest Laboratory Medicine, University of Western Australia, Perth, Australia.
700    1_
$a Wilemon, Katherine A $u FH Foundation, Pasadena, California.
700    1_
$a Benlian, Pascale $u CNRS, CHU Lille, UMR 8199 - Integrative Genomics and Metabolic Diseases Modeling, University of Lille, Lille, France.
700    1_
$a O'Connor, Robert $u Color Genomics, Burlingame, California.
700    1_
$a Garcia, John $u Invitae Corporation, San Francisco, California.
700    1_
$a Wand, Hannah $u Center for Inherited Cardiovascular Disease, Stanford University, Palo Alto, California.
700    1_
$a Tichy, Lukáš $u Center of Molecular Biology and Gene Therapy, University Hospital Brno, Brno, Czech Republic.
700    1_
$a Sijbrands, Eric J $u University Medical Center, Erasmus University, Rotterdam, Netherlands.
700    1_
$a Hegele, Robert A $u Robarts Research Institute, Western University, London, Ontario, Canada.
700    1_
$a Bourbon, Mafalda $u Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal. BioISI, University of Lisbon, Lisbon, Portugal.
700    1_
$a Knowles, Joshua W $u FH Foundation, Pasadena, California. Center for Inherited Cardiovascular Disease, Stanford University, Palo Alto, California.
710    2_
$a ClinGen FH Variant Curation Expert Panel
773    0_
$w MED00002078 $t Human mutation $x 1098-1004 $g Roč. 39, č. 11 (2018), s. 1631-1640
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30311388 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191014102354 $b ABA008
999    __
$a ok $b bmc $g 1451628 $s 1073518
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 39 $c 11 $d 1631-1640 $e - $i 1098-1004 $m Human mutation $n Hum Mutat $x MED00002078
GRA    __
$a PG08/008 $p British Heart Foundation $2 United Kingdom
GRA    __
$a U41 HG006834 $p NHGRI NIH HHS $2 United States
GRA    __
$a U41 HG009649 $p NHGRI NIH HHS $2 United States
GRA    __
$a U01 HG007436 $p NHGRI NIH HHS $2 United States
GRA    __
$a U41 HG009650 $p NHGRI NIH HHS $2 United States
GRA    __
$a U01 HG007437 $p NHGRI NIH HHS $2 United States
GRA    __
$a P30 DK116074 $p NIDDK NIH HHS $2 United States
GRA    __
$a NV16-29084A $p MZ0
LZP    __
$a Pubmed-20191007

Najít záznam

Citační ukazatele

Možnosti archivace